Anavex Life Sciences Corp (AVXL)

[gburgin]

Forgive my lack of patent knowledge but how can MediSynergics get away with using 2-73 in its application? I've gone back and read most of the excellent patent discussions on this board going back about a year and as I recall the consensus is that Anavex has a few more years of protection on the 2-73 molecule itself. If that is the case then MediSynergics would have to get permission from Anavex to use 2-73 correct? And of course there's no way Missling would agree to that. It seems to me the only way MediSynergics can get their patent is if the original patent on 2-73 has already expired and the composition of matter is no longer protected.